Entod Pharmaceuticals has introduced Colladerm, the first AI bio-engineered collagen transdermal gel serum, in the 54 th National Conference of Indian Association of Dermatologists
Natco Pharma shares jumped nearly 11% after the company received CDSCO approval to manufacture and market generic Semaglutide Injection in India, boosting investor sentiment and driving heavy trading volumes.
Novo Nordisk is preparing to introduce Wegovy in vial format, expanding delivery options for its blockbuster weight-loss drug as competition intensifies in the fast-growing obesity treatment market.
Dabur India today inaugurated its first south Indian manufacturing plant in Tindivanam, Tamil Nadu. The Rs 400 crore facility will produce popular personal care products and drive local employment.
USV Pharma is in advanced talks to acquire an 85% stake in Wellbeing Nutrition at a Rs 1,600 crore valuation, marking a major move into India’s fast-growing consumer health and supplements market.
Kashiv BioSciences has signed an exclusive licensing and supply agreement with Intas Pharmaceuticals to commercialize a complex peptide product across Europe, the UK, and India, expanding its global footprint.
Piramal Pharma has partnered with Blue-Zone Technologies to recycle waste anaesthetic gases through its subsidiary Piramal Critical Care, aiming to cut environmental impact while ensuring continued access to essential anaesthesia products.
Gujarat Chief Minister Bhupendra Patel praised the Union Budget 2026-27, highlighting significant allocations for the MSME, pharma, and semiconductor sectors. The budget aims to strengthen Gujarat’s industrial growth and improve liquidity.
Zydus Lifesciences has received tentative FDA approval for dapagliflozin tablets in 5 mg and 10 mg strengths. The drug, used to treat type 2 diabetes, will be manufactured at the company’s SEZ facility in Ahmedabad.
Sun Pharma is working to stabilize its US generics business as manufacturing issues ease, while pushing innovation-led growth, specialty launches, and preparing for the day-one launch of generic semaglutide in India.